Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases

• Príomhchruthaitheoirí: Anne E. Levine (Údar), Dominique Mark (Údar), Laila Smith (Údar), Hengqi B. Zheng (Údar), David L. Suskind (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2023-03-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Inflammatory bowel disease (IBD) is treated with a variety of immunomodulating and immunosuppressive therapies; however, for the majority of cases, these therapies are not targeted for specific disease phenotypes. Monogenic IBD with causative genetic defect is the exception and represents a disease...